Nutriband Inc. (NASDAQ: NTRB) and AVERSA™ Fentanyl: A Leap Forward in Opioid Safety and Market Recognition
Summary
Nutriband Inc. has achieved a significant milestone with the commercial-scale manufacturing of AVERSA™ Fentanyl, an abuse-deterrent opioid, in collaboration with Kindeva, marking a step forward in addressing the opioid crisis while gaining market recognition through inclusion in key indexes.
Full Article
What is AVERSA™ Fentanyl and why is it significant?
AVERSA™ Fentanyl is an abuse-deterrent opioid developed by Nutriband Inc. in partnership with Kindeva Drug Delivery. Its significance lies in its potential to address the global unmet need for safer pain management solutions amidst the opioid crisis, with technology protected by international patents.
How has Nutriband Inc. progressed towards FDA approval for AVERSA™ Fentanyl?
Nutriband and Kindeva have completed the commercial-scale manufacturing process for AVERSA™ Fentanyl, a critical milestone on the path to FDA approval, demonstrating strong execution and a favorable trial pathway.
What recent recognition has Nutriband Inc. received in the market?
Nutriband Inc. has been added to the Russel Indexes, boosting its profile and credibility in the market, alongside an updated analyst report raising its price target to $15.00 with an Outperform rating.
Why is the development of abuse-deterrent opioids like AVERSA™ Fentanyl important?
The development of abuse-deterrent opioids is crucial in balancing the medical necessity of pain management with public safety, addressing the high abuse potential of synthetic opioids like fentanyl during the ongoing opioid crisis.
Where can investors find the latest news and updates about Nutriband Inc.?
Investors can access the latest news and updates about Nutriband Inc. in the company’s newsroom at https://ibn.fm/NTRB.
What are the implications of Nutriband’s achievement for the opioid crisis?
Nutriband’s achievement in developing AVERSA™ Fentanyl represents a potential shift towards safer opioid use, offering a solution that could reduce abuse while still providing necessary pain relief, thus contributing to the fight against the opioid crisis.
Who is involved in the manufacturing of AVERSA™ Fentanyl?
Nutriband Inc. is collaborating with global contract manufacturer Kindeva Drug Delivery for the commercial-scale manufacturing of AVERSA™ Fentanyl, marking a partnership aimed at advancing safer opioid technologies.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 99396